Bipolar disorder Pharmaceuticals Self-awareness 
Mad in America
FEBRUARY 20, 2024
In recent years, there has been a growing awareness surrounding the adverse long-term effects of antidepressants, particularly concerning treatment-emergent sexual dysfunction (TESD). Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine.
Mad in America
NOVEMBER 7, 2023
In a study of patients with migraine headache, patients were aware that they might receive a placebo or an anti-migraine medication called Maxalt. Here, the balancing act is self-preservation, if you will, versus patient autonomy. After all, we do call these medications “anti-depressants”, right?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
DECEMBER 20, 2023
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. So even their self-judgment is not proof of the merits of the drugs, even for themselves, because they lack knowing what would have been possible for them.
Mad in America
OCTOBER 30, 2023
of the patients, and the authors said that their study “provides new evidence to suggest little to no relation between use of a selective serotonin reuptake inhibitor and self-reported suicidal ideation.” Insel is aware of this and promises to investigate why mental health outcomes in the United States are so poor. This is mendacious.
Mad in America
JANUARY 9, 2025
And thanks to education and awareness-raising efforts, more people are getting help with their suffering. Raising awareness about depression, screening for it, and teaching that its common but underdiagnosed, at first glance seem like good things. So its particularly easy to get them to adopt an inferior self-image.
Expert insights. Personalized for you.
142 
Let's personalize your content